Dr. John Forrest is a Professor of Medicine (Cardiology) at the Yale University School of Medicine. He currently serves as the Director of the Structural Heart Disease Program and Director of Interventional Cardiology at Yale New Haven Health System. Dr. Forrest is the national Principal Investigator for the Low Risk Evolut Trial and the Low Risk Bicuspid TAVR Study. In addition he serves on steering committee for EARLY TAVR Trial, the Apollo TMVR study, and currently sits on the TVT Registry Data workgroup.
